News - Baxter International, Financial


Popular Filters

Baxter buys exclusive rights to CTI’s cancer drug pacritinib


USA-based companies Baxter International and Cell Therapeutics have entered into an exclusive worldwide…

Baxter InternationalCell TherapeuticsFinancialGlobalLicensingOncologypacritinibPharmaceutical

Acquisition costs take toll on Baxter’s 3rd-qtr financials


USA-based Baxter International has posted solid financial results for the third quarter of 2013, showing…

Baxter InternationalFinancialHematologyPharmaceutical

Baxter to invest over $1 billion on new facility; post 1st-qtr results


USA-based Baxter International (NYSE:BAX) has announced plans to build a new state-of-the-art manufacturing…

Baxter InternationalFinancialPharmaceutical

Takeda and Daiichi Sankyo both get Japanese government grants for vaccine facilities


Japan’s largest drug company Takeda Pharmaceuticals (TYO: 4502) and fellow major Daiichi Sankyo…

Anti-viralsAsia-PacificBaxter InternationalDaiichi SankyoFinancialPharmaceuticalTakeda Pharmaceuticals

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top